Barclays’s AlerisLife Inc ALR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-20,211
| Closed | -$11.1K | – | 5506 |
|
|
2022
Q4 | $11.1K | Hold |
20,211
| – | – | ﹤0.01% | 4911 |
|
|
2022
Q3 | $19K | Sell |
20,211
-814
| -4% | -$935 | ﹤0.01% | 4086 |
|
|
2022
Q2 | $25K | Sell |
21,025
-324
| -2% | -$526 | ﹤0.01% | 4322 |
|
|
2022
Q1 | $46K | Buy |
+21,349
| New | +$57.2K | ﹤0.01% | 4152 |
|
|
2018
Q2 | – | Sell |
-18
| Closed | – | – | 7405 |
|
|
2018
Q1 | $0 | Buy |
+18
| New | +$261 | ﹤0.01% | 7437 |
|
|
2016
Q3 | – | Sell |
-436
| Closed | -$10K | – | 6868 |
|
|
2016
Q2 | $10K | Buy |
+436
| New | +$9.4K | ﹤0.01% | 5555 |
|
|
2015
Q4 | – | Sell |
-5,285
| Closed | -$159K | – | 6750 |
|
|
2015
Q3 | $159K | Buy |
5,285
+4,766
| +918% | +$181K | ﹤0.01% | 4299 |
|
|
2015
Q2 | $20K | Buy |
519
+389
| +299% | +$17.7K | ﹤0.01% | 5682 |
|
|
2015
Q1 | $5K | Sell |
130
-1,372
| -91% | -$51.7K | ﹤0.01% | 6611 |
|
|
2014
Q4 | $60K | Sell |
1,502
-2,736
| -65% | -$114K | ﹤0.01% | 5578 |
|
|
2014
Q3 | $126K | Sell |
4,238
-3,179
| -43% | -$144K | ﹤0.01% | 5140 |
|
|
2014
Q2 | $371K | Sell |
7,417
-6,150
| -45% | -$305K | ﹤0.01% | 4261 |
|
|
2014
Q1 | $542K | Sell |
13,567
-11,110
| -45% | -$629K | ﹤0.01% | 3884 |
|
|
2013
Q4 | $1.23M | Buy |
24,677
+8,044
| +48% | +$408K | ﹤0.01% | 3158 |
|
|
2013
Q3 | $832K | Buy |
16,633
+5,976
| +56% | +$331K | ﹤0.01% | 3565 |
|
|
2013
Q2 | $598K | Buy |
+10,657
| New | +$580K | ﹤0.01% | 4000 |
|
Barclays's ALR Position: Q1 2023 in Review
Barclays sold out of AlerisLife Inc (ALR) in Q1 2023, closing a stake of 20,211 shares — an estimated $11.1K sold.
Barclays first reported a position in ALR in Q2 2013 and held it in 16 quarters. The position peaked at $1.23M in Q4 2013. 1 fund tracked by Wall St. Rank holds ALR as of Q1 2023.
- Barclays reported no remaining AlerisLife Inc position as of Q1 2023 after selling out during the quarter.
- Barclays sold 20,211 AlerisLife Inc shares in Q1 2023, an estimated $11.1K.
- Barclays first reported a position in AlerisLife Inc in Q2 2013 and held it in 16 quarters.
- Barclays's AlerisLife Inc position peaked at $1.23M in Q4 2013.
- 1 fund tracked by Wall St. Rank held AlerisLife Inc as of Q1 2023.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.